Mettler-Toledo International (NYSE:MTD) issued its quarterly earnings results on Thursday. The medical instruments supplier reported $5.12 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $4.99 by $0.13, Briefing.com reports. Mettler-Toledo International had a return on equity of 90.80% and a net margin of 13.52%. The company had revenue of $734.85 million for the quarter, compared to the consensus estimate of $738.23 million. During the same quarter in the prior year, the business earned $4.36 EPS. Mettler-Toledo International’s revenue was up 5.2% on a year-over-year basis.
Shares of MTD traded up $12.72 during mid-day trading on Friday, reaching $608.03. The company’s stock had a trading volume of 446,389 shares, compared to its average volume of 181,918. Mettler-Toledo International has a 12-month low of $521.79 and a 12-month high of $697.26. The company has a market cap of $14.94 billion, a P/E ratio of 34.61, a PEG ratio of 2.38 and a beta of 1.15. The company has a debt-to-equity ratio of 1.92, a quick ratio of 1.06 and a current ratio of 1.46.
In other news, Director Robert F. Spoerry sold 1,836 shares of the stock in a transaction dated Monday, September 10th. The stock was sold at an average price of $600.00, for a total value of $1,101,600.00. Following the transaction, the director now owns 7,423 shares in the company, valued at approximately $4,453,800. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider William P. Donnelly sold 1,000 shares of the stock in a transaction dated Monday, August 27th. The shares were sold at an average price of $571.50, for a total value of $571,500.00. Following the completion of the transaction, the insider now owns 2,000 shares in the company, valued at approximately $1,143,000. The disclosure for this sale can be found here. In the last quarter, insiders sold 14,858 shares of company stock worth $8,681,504. Company insiders own 4.80% of the company’s stock.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Morgan Stanley grew its stake in Mettler-Toledo International by 47.9% during the 2nd quarter. Morgan Stanley now owns 74,688 shares of the medical instruments supplier’s stock worth $43,217,000 after buying an additional 24,177 shares during the last quarter. Trust Co. of Oklahoma purchased a new position in Mettler-Toledo International during the 3rd quarter worth approximately $853,000. Bessemer Group Inc. grew its stake in Mettler-Toledo International by 24.7% during the 2nd quarter. Bessemer Group Inc. now owns 3,055 shares of the medical instruments supplier’s stock worth $1,767,000 after buying an additional 605 shares during the last quarter. Ontario Teachers Pension Plan Board grew its stake in Mettler-Toledo International by 65.4% during the 2nd quarter. Ontario Teachers Pension Plan Board now owns 52,446 shares of the medical instruments supplier’s stock worth $30,347,000 after buying an additional 20,732 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. grew its stake in Mettler-Toledo International by 3.8% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 95,465 shares of the medical instruments supplier’s stock worth $55,239,000 after buying an additional 3,525 shares during the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.
Several equities research analysts have weighed in on the company. Morgan Stanley cut their price target on Mettler-Toledo International from $540.00 to $529.00 and set an “equal weight” rating on the stock in a report on Friday, July 27th. Zacks Investment Research upgraded Mettler-Toledo International from a “sell” rating to a “hold” rating in a report on Monday, July 30th. JPMorgan Chase & Co. upped their price target on Mettler-Toledo International from $550.00 to $600.00 and gave the stock a “neutral” rating in a report on Friday, July 27th. Finally, UBS Group assumed coverage on Mettler-Toledo International in a report on Tuesday, October 9th. They set a “neutral” rating and a $625.00 price target on the stock. Ten equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Mettler-Toledo International currently has a consensus rating of “Hold” and a consensus price target of $624.00.
COPYRIGHT VIOLATION NOTICE: “Mettler-Toledo International (MTD) Announces Quarterly Earnings Results” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/11/10/mettler-toledo-international-mtd-announces-quarterly-earnings-results.html.
About Mettler-Toledo International
Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.
Read More: How are Outstanding Shares Different from Authorized Shares?
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.